secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vitro Biopharma, Inc. (—)
CIK:        0000793171
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0001493152-23-024935
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vitro Biopharma issues $100K 8% convertible note with warrants to accredited investor
--------------------------------------------------------------------------------

- Sold $100,000 8% convertible promissory note to accredited investor; total proceeds $100,000.
- Note matures in 5 years; converts at qualified financing (≥$5M) or change of control at discounted or capped price.
- Capped price based on $200M pre-money valuation; discounted price is 75% of qualified financing price.
- Warrants to purchase shares at $0.625/share for 5 years; holder may participate in future qualified financing up to 200% of note principal.
- Securities sold under Rule 506 exempt registration; resale restrictions apply.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/793171/000149315223024935/0001493152-23-024935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/793171/000149315223024935/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer